FDA OKs stem cell therapy to reduce infection risk in blood cancer patients
was based on phase 3 testing that pitted the use of omidubicel in 62 patients against standard unmanipulated cord blood transplants in 63 patients following myeloablative conditioning.
The incidence of grade 2/3 bacterial or grade 3 fungal infections 100 days following transplant was 39% with omidubicel, vs 60% with standard transplants. The most common grade 3–5 adverse reactions in the approval study were pain , mucosal inflammation , hypertension , and gastrointestinal toxicity .
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Retired Houston Fire Department employee battling cancer seeking blood stem cell donorU.S. Army Veteran and retired Houston Fire Department employee Yolanda Lee is urgently seeking a lifesaving blood stem cell donor.
続きを読む »
Students up to the challenge at Mundelein STEM competitionSome of Lake County's brightest young minds face off Sunday during the 9th annual Mayor's Cup Stem Challenge at Mundelein High School.
続きを読む »
Tom Sandoval, Raquel Leviss Had Code Names For Each Other On Their Cell PhonesTom Sandoval and Raquel Leviss went to great lengths to keep their affair out of Ariana Madix's sight, even making fake names for each other on their phones, TMZ has learned ... despite Tom claiming she knew about all the warning signs.
続きを読む »
Drug suspect puts meth between buttocks, hides it in jail cell, gets busted againDuring a search Michigan police said they found Nathaniel K. Cipriani had a glass pipe in the waistband of his underwear and small baggies of suspected fentanyl were discovered stuffed beneath the …
続きを読む »
4 things you can do with your old cell phones and devicesMany of us have a drawer full of old cell phones, and a couple of old laptops in closet. Here are the best ways to recycle them, and possibly even get money.
続きを読む »
US approves Gamida's therapy to reduce infection risk in cancer patientsThe U.S. Food and Drug Administration said on Monday it had approved Gamida Cell Ltd's cell therapy to reduce the risk of infection in blood cancer patients.
続きを読む »